Controlled delivery of the anti-VEGF aptamer EYE001 with poly(lactic-co-glycolic)acid microspheres.
暂无分享,去创建一个
Joan W. Miller | E. Gragoudas | A. Adamis | Joan W Miller | Evangelos S Gragoudas | Anthony P Adamis | K. Carrasquillo | Karen G Carrasquillo | Joseph A Ricker | Ioannis K Rigas | Joseph A. Ricker | I. Rigas
[1] T. Higuchi. MECHANISM OF SUSTAINED-ACTION MEDICATION. THEORETICAL ANALYSIS OF RATE OF RELEASE OF SOLID DRUGS DISPERSED IN SOLID MATRICES. , 1963, Journal of pharmaceutical sciences.
[2] K. Griebenow,et al. Non-aqueous encapsulation of excipient-stabilized spray-freeze dried BSA into poly(lactide-co-glycolide) microspheres results in release of native protein. , 2001, Journal of controlled release : official journal of the Controlled Release Society.
[3] M. Alonso,et al. Formulation strategies for the stabilization of tetanus toxoid in poly(lactide-co-glycolide) microspheres. , 1999, International journal of pharmaceutics.
[4] P. Ma,et al. Biodegradable polymer scaffolds with well-defined interconnected spherical pore network. , 2001, Tissue engineering.
[5] S. Schwendeman,et al. Controlled-release of doxorubicin from poly(lactide-co-glycolide) microspheres significantly enhances cytotoxicity against cultured AIDS-related Kaposi's sarcoma cells. , 2000, Anticancer research.
[6] J. Urban,et al. The effect of hydration and matrix composition on solute diffusion in rabbit sclera. , 2000, Experimental eye research.
[7] K. Griebenow,et al. Reduction of structural perturbations in bovine serum albumin by non‐aqueous microencapsulation , 2001, The Journal of pharmacy and pharmacology.
[8] Sheela M. Waugh,et al. 2′-Fluoropyrimidine RNA-based Aptamers to the 165-Amino Acid Form of Vascular Endothelial Growth Factor (VEGF165) , 1998, The Journal of Biological Chemistry.
[9] M. Refojo,et al. Biodegradation and tissue reaction to intravitreous biodegradable poly(D,L-lactic-co-glycolic)acid microspheres. , 1995, Current eye research.
[10] Y. Ikada,et al. Microspheres of biodegradable polymers as a drug-delivery system in the vitreous. , 1991, Investigative ophthalmology & visual science.
[11] D. Putnam,et al. PLGA microspheres containing plasmid DNA: preservation of supercoiled DNA via cryopreparation and carbohydrate stabilization. , 1999, Journal of pharmaceutical sciences.
[12] Robert Langer,et al. Modeling monomer release from bioerodible polymers , 1995 .
[13] D. Wise,et al. Expression of liver-specific functions by rat hepatocytes seeded in treated poly(lactic-co-glycolic) acid biodegradable foams. , 2001, Tissue engineering.
[14] Jennifer I. Lim,et al. Human scleral permeability. Effects of age, cryotherapy, transscleral diode laser, and surgical thinning. , 1995, Investigative ophthalmology & visual science.
[15] R. D'Amato,et al. Intrachoroidal neovascularization in transgenic mice overexpressing vascular endothelial growth factor in the retinal pigment epithelium. , 2001, The American journal of pathology.
[16] S. Seregard,et al. Subfoveal fibrovascular membranes in age-related macular degeneration express vascular endothelial growth factor. , 1996, Investigative ophthalmology & visual science.
[17] C. A. van Blitterswijk,et al. In vitro biocompatibility testing of polylactides Part I Proliferation of different cell types , 1992 .
[18] T. Lindahl. Instability and decay of the primary structure of DNA , 1993, Nature.
[19] M. Prausnitz,et al. Measurement and Prediction of Transient Transport across Sclera for Drug Delivery to the Eye , 1998 .
[20] K. Griebenow,et al. Structure‐guided Encapsulation of Bovine Serum Albumin in Poly(DL‐lactic‐co‐glycolic) Acid , 1998 .
[21] J. Lang. Ocular drug delivery conventional ocular formulations , 1995 .
[22] H. Yang,et al. Long-acting delivery microspheres of levo-norgestrol-poly(3-hydroxybutyrate): their preparation, characterization and contraceptive tests on mice. , 2001, Journal of microencapsulation.
[23] T. Higuchi,et al. Rate of release of medicaments from ointment bases containing drugs in suspension. , 1961, Journal of pharmaceutical sciences.
[24] K. Griebenow,et al. Relationship between conformational stability and lyophilization‐induced structural changes in chymotrypsin , 2000, Biotechnology and applied biochemistry.
[25] Chung C. Hsu,et al. On the structural preservation of recombinant human growth hormone in a dried film of a synthetic biodegradable polymer. , 1999, Journal of pharmaceutical sciences.
[26] A. Klibanov,et al. Stability of Proteins and Their Delivery from Biodegradable Polymer Microspheres , 1996 .
[27] R. K. Evans,et al. Evaluation of degradation pathways for plasmid DNA in pharmaceutical formulations via accelerated stability studies. , 2000, Journal of pharmaceutical sciences.
[28] I. Morita,et al. Novel mechanism for age‐related macular degeneration: An equilibrium shift between the angiogenesis factors VEGF and PEDF , 2001, Journal of cellular physiology.
[29] D. Goeddel,et al. Vascular endothelial growth factor is a secreted angiogenic mitogen. , 1989, Science.
[30] E. J. Frazza,et al. A new absorbable suture. , 1971, Journal of biomedical materials research.
[31] J. Folkman. Angiogenesis in cancer, vascular, rheumatoid and other disease , 1995, Nature Medicine.
[32] C. M. Agrawal,et al. Sterilization, toxicity, biocompatibility and clinical applications of polylactic acid/polyglycolic acid copolymers. , 1996, Biomaterials.
[33] R. Langer,et al. A theoretical model of erosion and macromolecular drug release from biodegrading microspheres. , 1997, Journal of pharmaceutical sciences.
[34] H F Edelhauser,et al. Drug delivery for posterior segment eye disease. , 2000, Investigative ophthalmology & visual science.
[35] W. Middlesworth,et al. Combination antiangiogenic therapy: increased efficacy in a murine model of Wilms tumor. , 2001, Journal of pediatric surgery.
[36] T. Pan,et al. Applicability of urea in the thermodynamic analysis of secondary and tertiary RNA folding. , 1999, Biochemistry.
[37] H F Edelhauser,et al. Transscleral drug delivery for posterior segment disease. , 2001, Advanced drug delivery reviews.
[38] L. Aiello,et al. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. , 1994, The New England journal of medicine.
[39] 久納 紀之. Long-term sustained release of ganciclovir from biodegradable scleral implant for the treatment of cytomegalovirus retinitis , 2005 .
[40] T. Fitzwater,et al. A SELEX primer. , 1996, Methods in enzymology.
[41] M. Tso,et al. A histopathologic study of retinal lesions inflicted by transscleral iontophoresis , 2004, Graefe's Archive for Clinical and Experimental Ophthalmology.
[42] B Demple,et al. Repair of oxidative damage to DNA: enzymology and biology. , 1994, Annual review of biochemistry.
[43] C. Foster,et al. The Sclera , 1994, Springer New York.
[44] Tae Gwan Park,et al. Importance of in vitro experimental conditions on protein release kinetics, stability and polymer degradation in protein encapsulated poly (d,l-lactic acid-co-glycolic acid) microspheres , 1995 .
[45] K Miyamoto,et al. Transscleral delivery of bioactive protein to the choroid and retina. , 2000, Investigative ophthalmology & visual science.
[46] T. Meredith,et al. Principles and Practice of Ophthalmology , 1982 .
[47] D. Albert,et al. Principles and practice of ophthalmology , 1999 .
[48] Ivana K. Kim,et al. Diffusion of high molecular weight compounds through sclera. , 2000, Investigative ophthalmology & visual science.
[49] N. Janjić,et al. Oligonucleotide NX1838 inhibits VEGF165-mediated cellular responses in vitro , 1999, In Vitro Cellular & Developmental Biology - Animal.
[50] C. Blitterswijk,et al. In vitro biocompatibility testing of polylactides , 1993 .
[51] G. M. Iverson,et al. Immunospecific reduction of antioligonucleotide antibody-forming cells with a tetrakis-oligonucleotide conjugate (LJP 394), a therapeutic candidate for the treatment of lupus nephritis. , 1995, Journal of medicinal chemistry.
[52] D. Connolly,et al. Vascular permeability factor, an endothelial cell mitogen related to PDGF. , 1989, Science.
[53] M. Kamei,et al. A study of the ability of tissue plasminogen activator to diffuse into the subretinal space after intravitreal injection in rabbits. , 1999, American journal of ophthalmology.
[54] P. Carmona,et al. Conformational structure and binding mode of glyceraldehyde-3-phosphate dehydrogenase to tRNA studied by Raman and CD spectroscopy. , 1999, Biochimica et biophysica acta.
[55] Lois E. H. Smith,et al. Vascular endothelial growth factor/vascular permeability factor expression in a mouse model of retinal neovascularization. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[56] K. Griebenow,et al. Effect of excipients on the stability and structure of lyophilized recombinant human growth hormone. , 1998, Journal of pharmaceutical sciences.
[57] H F Edelhauser,et al. Human sclera: thickness and surface area. , 1998, American journal of ophthalmology.